Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

I would just note that the Adstiladrin CR rate at 12 months was 23% (46% of...

August 23, 2023

V.TLT

RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Right. I think the durable response rate of Ruvidar PDT will end up being as...

August 23, 2023

V.TLT

RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Nice post DJDawg. Yes, it looks like the results of N-803 plus BCG comes...

August 23, 2023

V.TLT

RE:FDA Breakthrough Therapy in 2023 …

It looks like there were 6 BTDs granted in 2023. 2 of them were for the...

August 22, 2023

V.TLT

RE:RE:RE:RE:Next week's trial result update

I think we already have fantastic clinical data and so far there's been...

August 21, 2023

V.TLT

RE:RE:Next week's trial result update

I don't know FGPstock. My guess would be that they don't have any...

August 21, 2023

V.TLT

We are totally blowing Keytruda out of the water

If we get a 450 day 41% durable complete response this will equal Keytruda...

August 21, 2023

V.TLT

RE:Next week's trial result update

It looks like we are headed for a 450 day CR rate of around 40% in 6 months...

August 21, 2023

V.TLT

Next week's trial result update

Next week we should get an update on the trial results. The last one we got...

August 21, 2023

V.TLT

New Cutting Edge Paper from Dr. McFarland and Colleagues

One of the problems with light activated photosensitizers is that light only...

August 14, 2023

V.TLT

RE:Next MD &A

We should get one before the end of of August - 3 weeks from now. Infinity...

August 10, 2023

V.TLT

RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

Just to add on to this - the FDA approved Adstiladrin based on CR rates of 51...

August 8, 2023

V.TLT

Theralase's ACT doesn't need to be the cure for cancer

In a recent interview Roger said: "The latest data that Theralase has...

August 4, 2023

V.TLT

Irish Researchers Cite TLD1433 in new paper

They mention the current phase 2 bladder cancer trial and also the Roswell...

August 4, 2023

V.TLT

Goodbye sedar - Hello sedarplus

Not quite as user friendly but you can still get at all the documents with a...

July 31, 2023

V.TLT

RE:RE:RE:RE:RE:RE:The cure for cancer From Princess Margaret Hospital

I thought this article on WebMD.com was a reasonable way to look at it. Not...

July 25, 2023

V.TLT

RE:RE:RE:The cure for cancer From Princess Margaret Hospital

Hi PBMTORBUST - I can't seem to find it but I read an interview with a...

July 24, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:How are the Ever Hopeful club members today .

But we could see those 2 move into the 360 day column and the 5 or 6 move...

July 18, 2023

V.TLT

RE:RE:RE:RE:RE:RE:How are the Ever Hopeful club members today .

I don't think so. At the end of November there could be 2 more 450 day CR...

July 18, 2023

V.TLT

johnsr1

check your messages

July 12, 2023

Featured Company